Mark Baum Biography and Net Worth

Chief Executive Officer and Chairman of the Board of Directors of Harrow

Mark L. Baum is the founder, Chairman of the Board, and Chief Executive Officer of Harrow. Mr. Baum is a founder and former board member of Eton Pharmaceuticals (Nasdaq: ETON) and Surface Ophthalmics, as well as a founder and the current Chairman of the Board of Melt Pharmaceuticals. From 2014-2017, Mr. Baum was a senior advisor to Curology.com. Before Harrow, as the founder of TBLF, LLC, a private investment fund manager, Mr. Baum made more than 200 investments in, and provided advisory and board service to, more than 40 private and public companies. In 1999, Mr. Baum founded YesRx, an HIV-focused pharmacy business. Mr. Baum actively advocates for patient and physician pharmaceutical accessibility issues, including being featured in Op-Ed contributions for the Wall Street Journal and appearances on national and international media outlets and other forums. Mr. Baum was named by Ernst & Young LLP as the 2017 Entrepreneur of the Year™ in the life sciences category for the San Diego region. Mr. Baum serves on the board of the Ophthalmology Foundation, which works with eye care professionals and professional societies to enhance and provide ophthalmic education, focusing on low-resource and underserved countries. Mr. Baum is a graduate, cum laude, of The University of Texas at Arlington and a 1997 graduate of California Western School of Law.

What is Mark L. Baum's net worth?: The estimated net worth of Mark L. Baum is at least $49.68 million as of March 22nd, 2024. Mr. Baum owns 2,137,525 shares of Harrow stock worth more than $49,676,081 as of April 22nd. This net worth evaluation does not reflect any other assets that Mr. Baum may own. Additionally, Mr. Baum receives an annual salary of $1,070,000.00 as Chief Executive Officer and Chairman of the Board of Directors at Harrow. Learn More about Mark L. Baum's net worth.
How old is Mark L. Baum?: Mr. Baum is currently 49 years old. There are 3 older executives and no younger executives at Harrow. Learn More on Mark L. Baum's age.
What is Mark L. Baum's salary?: As the Chief Executive Officer and Chairman of the Board of Directors of Harrow, Inc., Mr. Baum earns $1,070,000.00 per year. Learn More on Mark L. Baum's salary.
How do I contact Mark L. Baum?: The corporate mailing address for Mr. Baum and other Harrow executives is 102 Woodmont Blvd. Suite 610, Nashville TN, 37205. Harrow can also be reached via phone at (615) 733-4730 and via email at jwebb@harrowinc.com. Learn More on Mark L. Baum's contact information.
Has Mark L. Baum been buying or selling shares of Harrow?: Mark L. Baum has not been actively trading shares of Harrow over the course of the past ninety days. Most recently, on Friday, March 22nd, Mark L. Baum bought 9,000 shares of Harrow stock. The stock was acquired at an average cost of $11.59 per share, with a total value of $104,310.00. Following the completion of the transaction, the chief executive officer now directly owns 2,137,525 shares of the company's stock, valued at $24,773,914.75. Learn More on Mark L. Baum's trading history.
Who are Harrow's active insiders?: Harrow's insider roster includes Mark Baum (Chief Executive Officer and Chairman of the Board of Directors), and Richard Lindstrom, MD (Director). Learn More on Harrow's active insiders.
Are insiders buying or selling shares of Harrow?: In the last twelve months, Harrow insiders bought shares 2 times. They purchased a total of 31,715 shares worth more than $319,947.35. The most recent insider tranaction occured on April, 25th when Major Shareholder Opaleye Management Inc. bought 20,000 shares worth more than $199,400.00. Insiders at Harrow own 13.7% of the company. Learn More about insider trades at Harrow.
Information on this page was last updated on 4/25/2024.

Mark L. Baum Insider Trading History at Harrow

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/22/2024	Buy	9,000	$11.59	$104,310.00	2,137,525
11/16/2023	Buy	7,500	$8.11	$60,825.00	2,022,961
8/14/2023	Buy	5,800	$17.05	$98,890.00	2,015,461
12/22/2022	Buy	25,000	$13.39	$334,750.00	1,432,141
12/19/2016	Buy	156,000	$1.79	$279,240.00	325,835

Mark L. Baum Buying and Selling Activity at Harrow

Harrow Company Overview

Harrow, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in Nashville, Tennessee.

Today's Range

Now: $23.43

$23.26

$23.77

50 Day Range

MA: $25.99

$22.20

$31.91

2 Week Range

Now: $23.43

$9.86

$59.23

Volume

40,193 shs

Average Volume

460,047 shs

Market Capitalization

$835.19 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46

Mark Baum Biography and Net Worth

What is Mark L. Baum's net worth?

How old is Mark L. Baum?

What is Mark L. Baum's salary?

How do I contact Mark L. Baum?

Has Mark L. Baum been buying or selling shares of Harrow?

Who are Harrow's active insiders?

Are insiders buying or selling shares of Harrow?